Rifabutin
- Product NDC
- 72319-010
- 11-digit product format
- 723190010
- Labeler code
- 72319
- Product ID
- 72319-010_4efa116e-c5b0-d87e-e063-6394a90a5077
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rifabutin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- i3 Pharmaceuticals, LLC
- Application
- ANDA212430
- Marketing category
- ANDA
- Marketing start
- 2026-04-16
- Substance
- RIFABUTIN
- Active strength
- 150 mg/1
- Pharmacologic classes
- Rifamycin Antimycobacterial [EPC], Rifamycins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rifabutin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIFABUTIN | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1W306TDA6S |
| Rxcui | 198200 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72319-010-04 | Rifabutin | 100 in 1 BOTTLE | CAPSULE | 100 | | 6 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72319-010-04 | 72319001004 | 100 CAPSULE in 1 BOTTLE (72319-010-04) | 100 capsule | 2026-04-16 | No | No | Historical |